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ABSTRACT
Objective: It is unclear which exercise training protocol yields superior heart rate recovery (HRR) improvement in heart failure (HF) patients. 
Whether baseline HRR normality plays a role in the improvement is unknown. We hypothesized that an exercise training protocol and baseline 
HRR normality would be factors in altering HRR in HF patients.
Methods: In this prospective, randomized, controlled and 3 group parallel study, 41 stable HF patients were randomly assigned to 3-times-
weekly training sessions for 12 weeks, consisting of i) 30 minutes of interval training (IT) (n=17, 63.7±8.8 years old) versus ii) 30 minutes of 
continuous training (CT) (n=13, 59.6±6.8 years old) versus iii) no training (CON) (n=11, 60.6±9.9 years old). Each patient had cardiopulmonary 
exercise testing before and after the training program. Maximum heart rates attained during the test and heart rates at 1 and 2 min (HRR1 and 
HRR2) during the recovery phase were recorded. Paired samples t-test or Wilcoxon signed-rank test was used for comparisons before and 
after training. One-way ANOVA or Kruskal-Wallis variance analysis was used for comparisons among groups.
Results: HRR1 was unchanged after training. HRR2 improved in the IT group after training, and post-training HRR2 values were significantly 
faster in the IT group than in controls. Both HRR1 and HRR2 was significantly faster, irrespective of exercise protocol in patients with abnormal 
baseline values after training.
Conclusion: HRR1 did not improve after training. HRR2 improved only in the IT group. Both HRRs in patients with abnormal baseline values 
improved after both exercise protocols. IT might be superior to CT in improving HRR2. Baseline HRR might play a role in its response to exercise. 
(Anatol J Cardiol 2015; 15: 727-34)
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Introduction
Heart failure (HF), characterized by autonomic imbalance 
and neurohormonal activation, is a common disorder associated 
with high rates of morbidity and mortality (1). Autonomic imbal-
ance includes increased activity of the sympathetic system, 
decreased activity of the parasympathetic system, and 
depressed heart rate variability (2) and is a common clinical 
predictor of poor survival in HF (3, 4). Neurohormonal modula-
tion is consequently a cornerstone of modern heart failure treat-
ment (5). Current guidelines recommend that patients in cardiac 
rehabilitation (CR) programs perform moderate exercise at 
between 40% and 80% of peak heart rate (6, 7). Many of the 
effects are exerted by the interplay between the sympathetic 
and parasympathetic nervous systems. Heart rate at 1 or 2 min 
of recovery has been validated as a prognostic measurement 
(8). Heart rate recovery (HRR), as a simple and easily acquired 
response of autonomic function, has the potential to be an addi-
tional marker of training efficacy and risk stratification in 
patients undergoing CR. There may be an association of abnor-
mal HRR at baseline and at CR exit with all-cause mortality (9). 
CR may favorably affect HRR (10). Whether baseline HRR nor-
mality may play a role in the improvement of HRR is uncertain. 
CR improves symptoms, quality of life, and functional capacity in 
patients with HF, mainly by continuous aerobic training. Recent 
studies have suggested that interval cycle exercise training 
might also exert favorable effects (11). The data on the beneficial 
effects of aerobic exercise training on HRR in HF patients are 
limited. In addition, the effects of an exercise protocol on HRR 
are not fully characterized yet. A recent study by Dimopoulos et 
al. (12) demonstrated that continuous, rather than interval, exer-
cise training improved HRR1. In this prospective, randomized, 
controlled study, we assessed the effects of baseline HRR nor-
mality and interval versus continuous training on HRR in HF 
patients in order to better determine the influence of the exer-
cise protocol on this prognostic marker.
Methods
Participants
Patients were included in the study as follows: (1) adults of 
either gender and any age with satisfactory control of New 
York Heart Association Class II or III heart failure (asymptom-
atic at rest, mildly symptomatic on exertion, euvolemic, and 
normal renal functions); (2) any etiology of left ventricular 
systolic failure except aortic stenosis and hypertrophic cardio-
myopathy with significant gradient; (3) left ventricular ejection 
fraction between 30% and 45%; and (4) stable (>4 weeks) phar-
macologic therapy at the discretion of the treating physician. 
The diagnosis of HF was established by signs, symptoms, and 
an echocardiographically determined ejection fraction <45%. 
All participants had at least one previous hospital admission 
for HF and evidence of left ventricular dysfunction. Individuals 
with a history of pacemakers, acute coronary syndrome, acute 
stroke, New York Heart Association Class I and IV heart failure, 
occurrence of myocardial infarction within the previous 3 
months, previous ischemic stroke within the last 3 months, 
cardiac arrest, sustained arrhythmia, current angina, musculo-
skeletal or respiratory problems (such as COPD) or another 
comorbidity in which exercise is contraindicated or maximal 
effort is not attained, symptoms that prevent exercise, exer-
cise-induced symptomatic or sustained ventricular tachycar-
dia, and blood pressure drop during exercise test were 
excluded (Fig. 1).
Study design
At the time of CR initiation, a detailed history and physical 
examination were obtained. Greater than 70% of the study 
sample underwent cardiac revascularization (percutaneous 
intervention with angioplasty and stent or coronary artery 
bypass grafting surgery). None of the participants had revascu-
larization within the 3 months preceding the study. Participants 
were also followed for routine management of diet, weight, 
blood pressure, lipids, and diabetes mellitus. We did not make 
any medication changes. The study was designed as a prospec-
tive, randomized, controlled, 3-group parallel study. After a base-
line exercise tolerance test (ETT), participants were randomly 
allocated to an interval training group (IT) (n=17) or a continuous 
training group (CT) (n=13) or an inactive group (CON) (n=11) by 
our statistician, who was blinded to the clinical characteristics 
of the patients, and with the aid of a statistical software pack-
age. The training groups exercised for 12 weeks, involving 3 
sessions per week under physician supervision. Cycle ergome-
ters (Ergoline, Ergoselect II 100/200/Reha Model 2003, German) 
were used for aerobic exercise. Each session consisted of a 
5-minute warm-up and stretching period, followed by 30 minutes 
of aerobic exercise with an intensity of 50% to 75% of heart rate 
reserve, calculated by Karvonen formula, and ended with a 
5-min cool-down period (13). Patients in the IT group did aerobic 
exercise for 30 seconds at 50% to 75% of heart rate reserve, 
calculated by Karvonen formula, followed by rest intervals of 30 
seconds. Those randomized to CT exercised without resting 
intervals. CON continued with daily living activities.
Figure 1. Inclusion of the study population
Assessed for eligibility (n=60)
Excluded (n=11)
• Not meeting inclusion criteria (n=3)
• Declined to participate (n=5)
• Meeting exclusion criteria (n=3)
Randomized (n=49)
Allocated to interval training (n=17) Allocated to continuous training (n=16) Allocated to controls (n=16)
Interval training (n=17) Continuous training (n=13) Controls (n=11)
Final analysis Final analysis Final analysis
Excluded during Follow-Up
•   missing data, medication 
change, drop out, lost to 
follow up
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Maximal cardiopulmonary exercise test
Baseline stress tests were performed right before the initia-
tion of CR, and final stress tests were performed within 1 week 
of completion of CR. Resting heart rate and blood pressure val-
ues were recorded after 5 min of resting. Participants under-
went symptom-limited cardiopulmonary exercise testing with a 
stepwise exercise protocol performed on a bicycle (Technogym, 
Bike-Med, Italy) with breath measured by breath gas analysis 
(Masterscreen CPX, CareFusion Germany 234 GmbH, 2011). 
Pedaling speed was set at 60 revolutions per minute during the 
entire test. The power was increased by 10 watts starting from 
10 watts every minute until the appearance of symptoms. Blood 
pressure, heart rate, ECG, and symptoms were monitored every 
2 min and recorded at each stage. Measured aerobic capacity 
was expressed as peak O2 consumption (mL/kg/min). After peak 
exercise, the participant was required to undergo a 3-minute 
cool-down period, starting from 30 watts (corresponding to that 
at 1.5 mph and 2.5% grade on the treadmill, as suggested by 
previous work) (13) and decreasing 10 watts per min. HRR1 and 
2 were defined as the difference between heart rate at peak 
exercise and exactly 1 and 2 min into the recovery period. HRR1, 
HRR2, and cardiopulmonary measurements were recorded for 
each participant during cardiopulmonary exercise testing before 
and after CR. An HRR1 value less than or equal to 12 bpm was 
considered abnormal (14, 15). An HRR2 value less than or equal 
to 22 bpm was considered abnormal (8).
This study protocol was approved by the medical Ethics 
Review Committee of the participating university and conforms 
to the ethical guidelines of the 1975 Declaration of Helsinki. All 
participants gave written informed consent.
Statistical analysis
A statistical software package (SPSS 18.0, Chicago, IL, USA) 
was used to perform all analyses. Continuous and categorical 
data are reported as mean±standard deviation and percentages, 
respectively. Paired samples t-test or Wilcoxon signed-rank test 
assessed differences in variables at baseline and after CR, 
where appropriate. Comparisons among groups were assessed 
using one-way ANOVA or Kruskal-Wallis variance analysis. 
Tukey and Mann-Whitney U test with Bonferroni correction 
were used for post hoc comparisons. Differences in categorical 
data were assessed by chi-square analysis.
   Patients assigned to Patients assigned to 
 All patients Controls interval training continuous training 
 (n=41) (n=11) (n=17) (n=13) P
Age, years 61.3±8.4 60.6±9.9 63.7±8.8 59.6±6.8 0.407
Male, n (%) 35 (85) 9 (81.8) 13 (76.5) 13 (100) 0.93
BMI, kg/m2 29.4±4.8 29.3±4.8 28.7±4.9 30.1±5 0.599
Hypertension, n (%) 35 (85) 9 (81.8) 13 (76.5) 13 (100) 0.93
Diabetes mellitus, n (%) 16 (39) 4 (36.4) 6 (35) 6 (46.2) 0.978
Hyperlipidemia, n (%) 27 (65) 7 (63.6) 11 (64.7) 9 (69.2) 0.73
CAD, n (%) 38 (92) 10 (90.9) 13 (76.5) 13 (100) 0.294
Current smoking, n (%) 28 (68) 6 (54.5) 11 (64.7) 11 (84.6) 0.531
Alcohol, n (%) 13 (31) 4 (36.4) 4 (23.5) 5 (38.4) 0.858
Prior MI, n (%) 25 (60) 8 (72.7) 8 (47) 9 (69.2) 0.614
Prior CABG, n (%) 15 (36) 5 (45.5) 4 (23.5) 6 (46.2) 0.05
ACE inhibitors, n (%) 14 (34.1) 3 (27.3) 4 (23.5) 7 (53.8) 0.196
ARB, n (%) 9 (22) 3 (27.3) 5 (29.4) 1 (7.7) 0.270
Diuretics, n (%) 17 (41.5) 6 (54.5) 6 (35) 5 (38.5) 0.498
Beta-blockers, n (%) 21 (51.2) 5 (45.5) 6 (35) 10 (76.9) 0.311
Digitalis, n (%) 2 (4.9) 0 2 (11.8) 0 0.160
Nitrates, n (%) 12 (29.3) 4 (36.4) 5 (29.4) 3 (23) 0.384
Statins, n (%) 20 (48.8) 6 (54.5) 8 (47) 6 (46) 0.664
CCB, n (%) 4 (9.8) 1 (9.1) 2 (11.8) 1 (7.7) 0.929
Oral anti-diabetics, n (%) 11 (26.8) 3 (27.3) 5 (29.4) 3 (23) 0.926
Insulin, n (%) 3 (7.3) 1 (9.1) 1 (5.9) 1 (7.7) 0.949
Values are given as percentages or means±SD. ACE - angiotensin-converting enzyme; ARB - angiotensin receptor blocker; BMI - body mass index; CABG - coronary artery bypass 
grafting; CAD - coronary artery disease; CCB - calcium channel blocker; MI - myocardial infarction 
One way analysis of variance, Chi-square analysis
Table 1. Clinical and laboratory characteristics and medications in all patients and according to type of training
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Patients were also grouped as those with normal HRR1, 
abnormal HRR1, normal HRR2, and abnormal HRR2. Normal and 
abnormal groups (normal HRR1 vs. abnormal HRR1; normal HRR2 
vs. abnormal HRR2) were compared using independent samples 
t-test, Mann-Whitney U test, or chi-square analysis, where 
appropriate.
Results
Patients (n=41; New York Heart Association, II-III partici-
pants: mildly symptomatic on exertion; age, 61±8 years; 35:6, 
male:female) with either ischemic or non-ischemic cardiomy-
opathy were enrolled into the study. The IT group consisted of 17 
patients, the CT group consisted of 13 patients, and the controls 
were 11 patients. The patient groups were well matched for 
baseline clinical and laboratory characteristics and medications 
(Table 1). Age, sex, the presence of coronary artery disease 
(CAD), the risk factors for CAD, the use of alcohol, coronary 
revascularization, medications for heart failure, and diabetes 
were all similar among the groups. All participants underwent 
symptom-limited, maximal exercise tests. All participants com-
plied with the prescribed exercise protocol. We aimed for maxi-
mal effort. Tests were stopped largely due to fatigue. In all 
groups, the participation rates were greater than 90% at the time 
of follow-up testing, and there was no statistical difference 
among groups. The cardiopulmonary exercise testing responses 
of the overall group are demonstrated in Table 2. Significantly 
more patients with a normal baseline HRR1 were on beta-
blockers than those with an abnormal HRR1 (87% vs. 28%, 
p=0.0001) (Table 3). Significantly more patients with a normal 
baseline HRR2 were on beta-blockers than those with an 
abnormal baseline HRR2 (83% vs. 38%, p=0.01). Patients with an 
abnormal HRR2 were significantly older than those with a nor-
mal HRR2 (p=0.008). CR, irrespective of exercise protocol, 
improved HRR1 only in patients with abnormal baseline HRR1 
  Patients assigned Patients assigned 
 Controls to interval to continuous 
 (n=11) training (n=17) training (n=13)
 Pre- Post- P Pre- Post- P Pre- Post- P P 
 exercise exercise within* exercise exercise   within* exercise exercise within* between*
Resting heart rate, bpm 76±14 79±11 0.169 78±12 73±11 0.005* 78±13 68±7 0.007* 0.057
Peak heart rate, bpm  120±22 113±16 0.281 118±15 117±16 0.738 119±15 112±14 0.052 0.45
SBP at rest, mm Hg 124±15 127±16 0.146 123±13 117±10 0.01* 121±11 114±9 0.012* 0.022*
DBP at rest, mm Hg 85±8 85±9 0.80 80±9 78±9 0.154 82±6 72±8  0.002* 0.004*
Peak SBP, mm Hg 182±26 182±19 1.00 184±36 169±39 0.05* 184±27 164±15 0.007* 0.104
Peak DBP, mm Hg 97±8 98±6 0.705 103±27 92±11 0.026* 97±6 85±8 0.004* 0.002*
Absolute V O2, mL/kg/min 1104±479 918±370 0.003* 1214±347 1299±448 0.306 1119±294 1170±261 0.428 0.044*
Peak workload 96±51 83±40 0.077 97±22 116±31 0.002* 93±33 113±28 0.002* 0.031*
VE, mL 38±15 35±12 0.101 40±14 47±15 0.032* 44±10 44±10 0.912 0.077
V CO2, mL 1019±474 954±401 0.175 1020±297 1210±420 0.032* 1126±301 1193±281 0.119 0.184
Peak absolute V O2, mL/ 14±6 11±5 0.002* 15±6 17±7 0.281 14±4 14±3 0.399 0.035* 
kg/min
V ‘E/V’ CO2 0.04±0.005 0.038±0.004 0.044* 0.06±0.09 0.04±0.005 0.492 0.04±0.004 0.037±0.002 0.016* 0.222
HRR1 13±12 11±9 0.684 9±5 11±6 0.123 16±11 14±4 0.517 0.159
HRR2 22±17 19±16 0.131 17±9 24±8 0.03* 24±9 23±6 0.689 0.045*
Values are given as means±SD. DBP - diastolic blood pressure; HRR - heart rate recovery; SBP - systolic blood pressure; V CO2 - carbon dioxide output; VE - minute ventilation; V ‘E/V’ CO2 
- ventilatory equivalent of carbon dioxide; V O2 - oxygen uptake. 
*P within: P value for the within-patient comparison, i.e., pre- vs. post-exercise. 
*P between: P value for the between-group (controls vs. interval vs. continuous) comparison of the post-exercise group difference (i.e., systolic blood pressure at rest, controls vs. 
continuous; diastolic blood pressure at rest, controls vs. continuous; peak diastolic blood pressure, controls vs. continuous; absolute V O2, controls vs. interval; peak workload - controls 
vs. interval; peak absolute V O2, controls vs. interval; HRR2, controls vs. interval) 
One way analysis of variance, Kruskal- Wallis variance analysis
Table 2. Comparison of cardiopulmonary exercise testing responses of the study population
 Overall Normal Abnormal 
 group baseline baseline P
HRR1
Beta-blockers, n (%) 21 (51.2) 14 (87) 7 (28) 0.0001*
HRR2
Age, years 61±8 56±8 64±8 0.008*
Beta-blockers, n (%) 20 (53) 10 (83) 10 (38) 0.01*
Values are given as percentages or means±SD. 
*difference between subgroups 
Independent samples t-test, Chi-square analysis
Table 3. Differences in key clinical characteristics in the overall group 
and HRR subgroups
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values (Table 4). Only the IT protocol improved HRR2. HRR1 val-
ues were unchanged after exercise training in all groups 
(Fig. 2A). When only participants with an abnormal baseline 
HRR1 were analyzed, HRR1 values were significantly faster (6±3 
vs. 12±6 bpm, p=0.013). HRR1 in patients with a normal baseline 
HRR1 were unchanged after CR (Fig. 2B) (Table 4). There was no 
difference among exercise protocols with respect to the 
improvement in HRR1 in those patients with an abnormal base-
line HRR (p=0.180). HRR2 values were significantly faster only in 
the IT group after exercise training (17±9 vs. 24±8 bpm, p=0.03) 
(Fig. 3A). After CR, HRR2 values were significantly faster in the 
IT group than in controls (19±16 vs. 24±8 bpm, p=0.045) (Table 2). 
HRR2 in patients with a normal baseline HRR2 were unchanged 
after CR (Fig. 3B).
Before CR, 41% of the patients had a normal HRR1 versus 59% 
with an abnormal HRR1. After CR, 51% had a normal HRR1 and 
49% had an abnormal HRR1. Before CR, 31.6% of the patients had 
a normal baseline HRR2 versus 68.4% with an abnormal baseline 
HRR2. After CR, 47.5% had a normal HRR2 versus 52.5% with an 
abnormal HRR2. There were no normality group differences 
among HRR groups when HRR normality considered.
There were no differences in blood pressure, heart rate, or 
VO2 values among normal and abnormal HRR1 groups. The nor-
mal HRR2 group had significantly higher peak absolute V02, VE, V 
CO2, V ‘E/V’ CO2, and peak workload than the abnormal HRR2 
group (p<0.05).
There were 13 patients with an abnormal HRR1 in the IT 
group; 4 patients with an abnormal HRR1 in the CT group; and 7 
patients with an abnormal HRR1 in the CON group (p: 0.026). 
There were 13 patients with an abnormal HRR2 in the IT group; 7 
patients with an abnormal HRR2 in the CT group; and 6 patients 
with an abnormal HRR2 in the CON group (0.334). Regarding, 
HRR1 changes, there were no differences among the groups (IT, 
p=0.688; CT, p=1.00; CON, p=1.00). Regarding, HRR2 changes, 
there were no differences among the groups (IT, p=0.125; CT, 
p=0.453; CON, p=1.00).
Discussion
The main finding of the current study was that HRR1 did not 
improve after CR; however, HRR1 improved in only patients with 
abnormal baseline HRR1 values, irrespective of exercise proto-
Figure 2. a, b. Heart rate recovery at 1 min (HRR1) of the overall group in the 3 training subgroups pre- and post-rehabilitation (a). HRR1 in the 
HRR1 subgroups according to baseline normality (b)
























































 Pre-exercise Post-exercise P within* Pre-exercise Post-exercise P within* P between*
HRR1 20±9 14±7 0.053 6±3 12±6 0.013* 0.057
HRR2 27±14 23±12 0.144 16±7 21±9 0.03* 0.890
HRR1 is considered normal when >12 and abnormal when ≤12. 
HRR2 is considered normal when >22 and abnormal when ≤22. 
*P within: P value for the within-patient comparison, i.e., pre- vs. post-exercise. 
*P between: P value for the between-group (normal vs.abnormal) comparison of the post-exercise group difference 
Independent samples t test
Table 4. Comparison of cardiopulmonary exercise testing responses of heart rate recovery at 1 min (HRR1) and 2 min (HRR2) according to baseline 
HRR1 and HRR2 normality
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col. The current study is the first to our knowledge to show that 
HRR2 improved after CR. Our results indicate that HF patients 
with abnormal baseline HRR1 (less than or equal to 12 bpm) can 
improve their HRR1 after the completion of a 12-week aerobic 
interval or continuous CR program. However, the interval CR 
program might be superior to the continuous CR program in 
improving HRR2, which is a better predictor of mortality (8). The 
results in the current study require confirmation by larger ran-
domized trials.
A growing body of evidence in recent years has shown that 
HRR is associated with all-cause and cardiovascular mortality, 
particularly in patients with abnormal baseline HRR (16-21). 
Previous studies have shown that heart rate reduction plays a 
critical role in the improvement of clinical outcomes in heart 
failure. Numerous investigators have observed that exercise 
training in patients with cardiovascular disease increases HRV 
(22, 23). Training may have a considerable effect on outcomes in 
patients with HF via altered vagal modulation. In this study, a 
significant improvement was observed among those with abnor-
mal baseline HRR1. The response was similar in both the interval 
and continuous training groups, despite that the 2 exercise pro-
tocols are not isocaloric. This is in accordance with Streuber et 
al. (24), who reported that abnormal baseline HRR1 was the pri-
mary factor in determining whether exercise training would 
improve HRR1 in HF patients. In this study, HRR2 improved only 
in the IT group, which was in line with the significant improve-
ments in fitness levels of the group (Table 2). This can be consid-
ered an extension of previous studies, in that IT might be supe-
rior to CT in improving HRR2. Especially, HRR2 was found to be 
superior to all other time periods as a mortality predictor (8).
A few studies demonstrated that different exercise proto-
cols, including walking on a treadmill or unsupervised walking, 
improved HRR in HF patients (25, 26). Although we observed 
improvements in some parasympathetic parameters, such as 
resting heart rates, systolic blood pressures at rest and exer-
cise, and diastolic blood pressures at rest and exercise, a sig-
nificant number of our patients did not improve their HRR1. It is 
unclear why training, irrespective of exercise protocol, failed 
to improve HRR in our patients, especially in those with normal 
baseline HRR responses. Perhaps vagal tone in this patient 
group was relatively unimpaired compared with those with 
abnormal baseline HRR responses; thus, there was not enough 
room for parasympathetic activity to improve further. Those 
patients with normal baseline HRR responses might have 
required a greater training stimulus to improve their HRR, 
because HRR improvement in HF patients with higher initial 
exercise capacities may require greater training intensities. 
We used cycle ergometry for training, which might have led to 
lower exercise stimulus due to leg fatigue. Absolute peak oxy-
gen uptake did not improve, regardless of baseline HRR1 or 
HRR2 normality, which can also be explained by the fact that 
the patients might have exercised at 50% of their heart rate 
reserve, although we asked for maximal effort. We allowed 
them to exercise at 50% to 75% of their reserve, as they toler-
ated. The improvement of autonomic responsiveness by exer-
cise training in HF patients, assessed by HRR improvement, 
could require longer exercise program duration. Nonetheless, 
Tsarouhas et al. (25) suggested in their report that the potential 
favorable effects of exercise, irrespective of baseline HRR1 
values, on endothelial and musculoskeletal metabolism led to 
HRR1 improvement in their patients. HRR2 normalized in more 
patients with abnormal baseline values than HRR1. Whereas 
HRR1 can be considered a marker of cardiac parasympathetic 
outflow, HRR2 is thought to be related to the gradual with-
Figure 3. a, b. Heart rate recovery at 2 min (HRR2) of the overall group in the 3 training subgroups pre- and post-rehabilitation (a). HRR2 in the 
HRR2 subgroups according to baseline normality (b)
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drawal of sympathetic activity (27). A CR program, especially 
IT, might be more effective in the withdrawal of sympathetic 
activity.
The current study confirms the benefits of both exercise 
protocols in HF patients with abnormal baseline HRR1. Our find-
ings are consistent with those of Streuber et al. (24), who also 
observed that short-term aerobic training can favorably modify 
HRR1 in HF patients with low exercise capacity. In contrast, 
Dimopoulos et al. (12) recently reported that HRR1 improved only 
among subjects in the continuous training group, although they 
did not mention what percentage of patients had an abnormal 
baseline HRR. Whether patients largely had an abnormal baseline 
HRR or the recovery protocol, the training stimulus that was used 
may explain the differences between our study and that study. 
Their study also lacked a control group. In the current study, HRR2 
improved only among subjects in the IT group. Given the differ-
ences in methods, direct comparisons between the 2 studies are 
not possible, but our study showed that HRR2, as a superior pre-
dictor, was significantly faster after IT compared to controls.
More recently published data showed significant improvements 
in fitness levels following high-intensity interval and moderate-
intensity endurance exercise training in patients with coronary 
artery disease. However, they demonstrated no change in HRR and 
heart rate variability. Their pre-training HRR values were in a low-
risk range; thus, they suggested that training-induced improve-
ments may only be achievable in populations with attenuated pre-
training values (28). The observed differences in HRR between 
studies may be due to differences in clinical characteristics, exer-
cise protocols, the recovery protocol, and weight-bearing status. 
The recovery protocols employed in studies that have examined 
HRR vary. In the current study, participants underwent a 3-minute 
cool-down period, starting from 30 watts [corresponding to that used 
in the study by Cole et al. (14)] and decreasing 10 watts per min.
In contrary to the common assumption that high-exertion 
exercise increases diagnostic sensitivity, Cahalin et al. (29) just 
recently demonstrated that the prognostic significance of HRR 
does not depend upon maximal effort. In view of this, the recom-
mendation for HF patients to exercise as maximally as possible 
may be unnecessary when examining HRR for prognostic pur-
poses. Thus, our study is relevant, as we aimed to achieve 80% of 
maximum heart rate or anaerobic threshold limited by symptoms 
during the cycle ergometry exercise. HRR1 reflects the recovery 
of parasympathetic activity after maximal exercise. In this study, 
only a small number of patients normalized their HRR1 after CR. 
This is in line with the previously mentioned findings of some 
investigators (9, 12, 24, 30). One of the possibilities is that parasym-
pathetic recovery may remain impaired in some HF patients, 
despite CR. Another potential explanation for the lack of HRR 
improvement may be the presence of some clinical characteris-
tics, including older age, peripheral arterial disease, diabetes mel-
litus, and the use of nitrates, as suggested by Jolly et al. (9). Yet, 
another possibility is that 36% of the overall group had CABG 
operation, and the cardiac innervations might have been affected. 
In addition, the compliance with medications for the overall group, 
especially those with abnormal HRR values, is unacceptably low. 
None of the patients had a hospitalization for HF or revasculariza-
tion in the 3 months preceding the study. Therefore, the lack of 
improvement in HRR may also be attributed to the time at which 
the training was initiated, as suggested by Currie et al. (28).
Study limitations
We had to exclude several participants because of medica-
tion change and missing data, and we also experienced several 
dropouts during the training intervention; therefore, our sample 
was smaller than desired. Our study largely included patients 
with HF with an ischemic etiology after MI; thus, the results may 
not be applicable to the wider population of HF patients. Thirty-
six percent of our patients had undergone CABG, in whom both 
afferent and efferent cardiac innervations might have been 
impaired. The rate of evidence-based medication use is unac-
ceptable. However, the power of the current study comes from 
its prospective nature, as the majority of large studies examining 
HRR after exercise has been retrospective.
Conclusion
Training in HF patients with abnormal baseline HRR resulted 
in improvements in this prognostic marker, more so in HRR2 than 
HRR1. Both exercise protocols (i.e., interval or continuous) are 
suitable for HRR1 improvement. IT might be superior to CT in 
improving HRR2. However, HRR remains unimproved in a signifi-
cant number of patients, which corroborates prior studies that 
have shown similar results. Further research should focus on 
optimizing the most efficient protocol of exercise and the length 
of the rehabilitation program with respect to HRR improvement 
and identifying appropriate HF patient groups to target.
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